 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...

AtriCure Announces Launch of the cryoSPHERE+ Probe for Post-Operative Pain Management

Latest Ratings for ATRC
 DateFirmActionFromTo Feb 2022Canaccord GenuityMaintainsBuy Feb 2022NeedhamMaintainsBuy Nov 2021NeedhamMaintainsBuy
 View More Analyst Ratings for ATRC

 View the...

Key Takeaways From AtriCure Analyst Ratings

AtriCure to Announce First Quarter 2024 Financial Results

AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,970,000 shares, an...

AtriCure, Inc. (NASDAQ:ATRC) Sees Large Growth in Short Interest

This is a signal that ATRC's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

AtriCure (ATRC, $30.13) RSI Indicator left the oversold zone on March 27, 2024

AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference

AtriCure, Inc. (NASDAQ:ATRC  Get Free Report)s stock price fell 3.8% on Wednesday following insider selling activity. The stock traded as low as $30.20 and last traded at $30.31...

AtriCure (NASDAQ:ATRC) Trading Down 3.8% Following Insider Selling

AtriCure (ATRC, $30.49) RSI Indicator left the oversold zone on March 20, 2024

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Does AtriCure (NASDAQ:ATRC) Have A Healthy Balance Sheet?

This is a Bearish indicator signaling ATRC's price could decline from here. Traders may explore shorting the stock or put options...

AtriCure (ATRC, $33.99) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 13, 2024

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Volume (M)	470,018.00
52-Wk High	$59.61
52-Wk Low	$22.42

ATRC Atricure Inc

About

Feed

News

Sentiment

Earnings

Fundamentals